Diclofenac Sodium Price Index: Trend, Chart, Market Analysis and Forecast 2026

Author : ChemAnalyst Data | Published On : 09 Oct 2026

According to ChemAnalyst, The global Diclofenac Sodium Prices experienced a downward trend during the second quarter of 2026, as cautious pharmaceutical procurement, distributor destocking, and competitive export offers weighed on pricing across North America, Asia-Pacific (APAC), and Europe. Market participants adopted a conservative purchasing approach, prioritizing inventory optimization and limiting spot-market commitments amid sufficient active pharmaceutical ingredient (API) availability.

In North America, prices declined as distributors reduced inventories and buyers benefited from competitive Asian offers. In China, subdued spot demand and export competition contributed to a further decrease in the Diclofenac Sodium Price Index. Meanwhile, the European market recorded a moderate correction, reflecting cautious purchasing by pharmaceutical manufacturers and adequate regional API supply.

The overall market environment during Q2 2026 was characterized by limited upward pricing pressure, with buyers focusing on cost control, supplier negotiations, and inventory management. Although regional market conditions differed, the decline across all three major markets indicated a broadly soft pricing environment for Diclofenac Sodium.

Diclofenac Sodium Prices in North America

US Diclofenac Sodium Price Trend in Q2 2026

In the United States, the Diclofenac Sodium Price Index declined by 3.199% quarter-over-quarter in Q2 2026, reflecting distributor destocking and competitive import offers. The average Diclofenac Sodium price during the quarter was approximately USD 8,170/MT, based on the supplied market assessment.

The decline was primarily associated with a cautious procurement environment in which pharmaceutical distributors and buyers concentrated on managing existing inventories rather than increasing purchasing volumes. Following earlier procurement cycles, market participants increasingly prioritized stock utilization and reduced the urgency of fresh spot-market purchases. This shift limited immediate demand for additional Diclofenac Sodium supplies and placed downward pressure on transaction prices.

Competitive Asian offers also influenced the North American pricing environment. Importers evaluating international sourcing opportunities could compare domestic quotations with overseas supply offers, strengthening their negotiating position. When imported material is available at competitive prices, domestic suppliers may face pressure to adjust quotations or offer more flexible commercial terms to maintain customer relationships.

However, the impact of international offers on actual procurement costs depends on freight rates, import lead times, quality requirements, regulatory compliance, and supplier qualification. Consequently, lower export quotations do not necessarily translate into an equivalent reduction in delivered prices for every buyer.

Get Real Time Online for Diclofenac Sodium Prices: https://www.chemanalyst.com/Pricing-data/diclofenac-sodium-1421

Demand Conditions and Procurement Behaviour

Demand for Diclofenac Sodium is closely connected to pharmaceutical manufacturing requirements, particularly the production of anti-inflammatory and pain-relief medicines. Procurement activity can vary according to finished-dose manufacturing schedules, prescription and over-the-counter product demand, inventory policies, and customer order patterns.

During Q2 2026, the US market reflected a preference for controlled purchasing rather than aggressive inventory accumulation. Buyers were more likely to place orders according to immediate production requirements and confirmed downstream demand. This approach reduced the volume of speculative procurement and limited the ability of suppliers to maintain higher quotations.

Distributor destocking played an important role in the quarterly price movement. When distributors seek to reduce inventory, they may postpone replenishment, offer existing material to customers, or prioritize the clearance of available stocks. Such measures can weaken near-term purchasing activity even when underlying pharmaceutical consumption remains relatively stable.

Supply Availability and Import Competition

International sourcing remained an important factor in shaping US Diclofenac Sodium Prices. Asian manufacturers and exporters can influence the competitive landscape through their production costs, available capacity, export pricing, and willingness to negotiate with overseas buyers.

The presence of competitive offers encouraged North American purchasers to assess alternative suppliers and compare total landed costs. In addition to the quoted API price, procurement teams typically evaluate shipping expenses, customs-related charges, documentation, testing requirements, and delivery reliability.

For suppliers, the combination of sufficient availability and cautious buying conditions created a challenging environment for price increases. Maintaining customer relationships, securing repeat orders, and offering dependable delivery schedules became important competitive priorities.

North America Market Outlook

The North American Diclofenac Sodium market closed Q2 2026 on a softer footing, with the 3.199% quarterly index decline reflecting inventory adjustment and import competition. In the near term, price movements are likely to depend on distributor replenishment, pharmaceutical production schedules, the competitiveness of Asian offers, and changes in logistics costs.

A sustained recovery in purchasing activity could help stabilize prices if distributors begin rebuilding inventories. Conversely, continued destocking and readily available imports could maintain downward pressure. Any improvement in pricing would therefore depend on a clearer recovery in procurement demand rather than supply competition alone.

Diclofenac Sodium Prices in APAC

China Diclofenac Sodium Price Trend in Q2 2026

In China, the Diclofenac Sodium Price Index decreased by 3.86% quarter-over-quarter during Q2 2026, reflecting subdued spot buying and competitive export conditions. The average price was approximately USD 7,980/MT, based on the supplied CFR Shanghai market assessment.

The decline highlighted a market environment in which buyers remained cautious about purchasing additional material. Rather than committing to large volumes in anticipation of higher prices, market participants focused on near-term requirements and inventory availability. This restrained spot-market activity and reduced the scope for suppliers to command higher prices.

China also plays an important role in the international pharmaceutical ingredients supply chain. Export competition can therefore influence domestic trading sentiment and the prices offered to international customers. When several suppliers compete for limited orders, exporters may adjust quotations, negotiate contract terms, or offer more competitive pricing to secure business.

The quarterly decline in the Chinese Diclofenac Sodium Price Index was consistent with this competitive environment. However, the movement should not be interpreted as evidence of a uniform decline in every transaction, since actual prices can vary according to order volumes, product specifications, quality documentation, and contractual arrangements.

Impact of Export Competition on Prices

Export competitiveness remained a central consideration for Chinese Diclofenac Sodium suppliers during the quarter. Manufacturers seeking to maintain shipment volumes faced the challenge of balancing production economics with buyers' expectations for competitive quotations.

International customers generally compare suppliers on more than price alone. Factors such as product quality, regulatory documentation, manufacturing consistency, delivery schedules, and long-term supply reliability can affect supplier selection. Nevertheless, when specifications and qualification requirements are comparable, lower-priced offers can influence purchasing decisions and intensify competition.

For exporters, a softer pricing environment may encourage a greater emphasis on production efficiency, inventory turnover, and customer retention. Manufacturers with effective cost management and reliable operating performance may be better positioned to remain competitive without making disproportionate reductions in their selling prices.

The relationship between export quotations and the CFR Shanghai assessment also requires careful interpretation. CFR pricing incorporates the cost and freight components associated with delivery to the named destination, subject to the specific contractual terms. Changes in freight costs and shipment conditions can therefore affect delivered assessments independently of the underlying manufacturing cost.

Demand and Inventory Trends in APAC

The APAC pharmaceutical ingredients market is influenced by regional medicine production, domestic procurement, export orders, and the availability of competing suppliers. In China, subdued spot buying during Q2 2026 reduced the urgency of fresh purchases and contributed to weaker pricing momentum.

Buyers operating under cost-control targets may prefer shorter purchasing cycles when supply is readily available. This reduces the risk of holding excess inventory and allows procurement teams to respond to changing quotations. However, lean inventory policies also require careful coordination with suppliers to avoid interruptions in pharmaceutical manufacturing.

Demand recovery could support market stabilization if pharmaceutical producers increase order volumes or distributors return to more regular replenishment schedules. A stronger export order book could also improve suppliers' pricing positions. Until such improvements become evident, competitive quotations and cautious purchasing are likely to remain influential market factors.

APAC Market Outlook

China's Diclofenac Sodium market recorded the steepest quarterly index decline among the three regions covered in this assessment, falling by 3.86% in Q2 2026. The average price of approximately USD 7,980/MT reflected the supplied CFR Shanghai assessment.

Future price movements will depend on the balance between domestic spot demand, export order volumes, production costs, and logistics conditions. Stronger overseas demand or tighter supply could support prices, while persistent competition among exporters and limited spot buying could prolong the downward trend.

For international buyers, China remains an important market to monitor when evaluating sourcing alternatives. Nevertheless, procurement decisions should account for total delivered cost, supplier qualification, product quality, and consistency of supply rather than relying exclusively on headline price assessments.

Diclofenac Sodium Prices in Europe

Germany Diclofenac Sodium Price Trend in Q2 2026

In Germany, the Diclofenac Sodium Price Index declined by 2.64% quarter-over-quarter in Q2 2026, reflecting cautious pharmaceutical procurement and sufficient API availability. The average Diclofenac Sodium price for the quarter was approximately USD 8,050/MT, based on the supplied CFR Hamburg market assessment.

The German market experienced a moderate price correction as buyers maintained a disciplined approach to procurement. Pharmaceutical manufacturers and ingredient distributors continued to evaluate inventory requirements carefully, limiting unnecessary purchases and emphasizing cost efficiency.

Sufficient API availability reduced the immediate need for buyers to secure additional material at higher prices. When buyers can access adequate supplies from existing inventories or qualified suppliers, they have greater flexibility to negotiate purchase terms and schedule replenishment according to operational needs.

The decline in the German index was smaller than the corresponding reductions in the US and Chinese assessments. This difference suggests that regional market dynamics were not identical. Procurement practices, supplier relationships, import economics, and the balance between available supply and immediate demand can all contribute to variations in quarterly price movements.

Pharmaceutical Procurement and Supply Availability

Germany's pharmaceutical sector operates within a quality-sensitive procurement environment. Buyers sourcing Diclofenac Sodium must consider product specifications, documentation, manufacturing standards, traceability, and supplier qualification alongside the commercial price.

These requirements can limit the extent to which buyers switch suppliers solely in response to lower international quotations. A competitively priced API may not be a suitable alternative unless it meets the purchaser's quality and regulatory requirements and has completed the necessary qualification procedures.

During Q2 2026, sufficient API availability and cautious purchasing contributed to a softer price environment. Buyers could focus on negotiated procurement arrangements, inventory planning, and supplier performance instead of making urgent purchases to address shortages.

At the same time, suppliers continued to face pressure to remain commercially competitive. Reliable delivery, consistent quality, responsive customer service, and transparent documentation can help differentiate suppliers when market prices are moving downward.

Import Costs and the CFR Hamburg Assessment

The reported average price of approximately USD 8,050/MT was based on the CFR Hamburg market assessment provided for this analysis. CFR assessments include cost and freight to the named destination under the relevant contractual arrangement, but they should not automatically be treated as equivalent to a fully landed or warehouse-delivered price.

Additional expenses may arise depending on the transaction, including insurance where arranged separately, customs-related charges, handling, testing, storage, and inland transportation. Currency movements and changes in shipping costs can also influence the final purchasing cost for European buyers.

Consequently, procurement teams should compare quotations using consistent delivery terms and product specifications. Comparing an export price with a delivered warehouse price without adjusting for the differences can lead to misleading conclusions about supplier competitiveness.

Europe Market Outlook

The European Diclofenac Sodium market ended Q2 2026 with a 2.64% quarterly index decline. The combination of sufficient API availability and cautious procurement limited upward pricing pressure, while the quality-sensitive nature of pharmaceutical sourcing remained an important consideration.

In the coming quarters, price direction will depend on purchasing volumes, supplier availability, international export competition, and logistics expenses. A recovery in pharmaceutical procurement could help stabilize assessments, whereas continued inventory discipline and competitive import offers could keep prices under pressure.

For German buyers, maintaining a diversified pool of qualified suppliers and monitoring total procurement costs may help manage price volatility without compromising supply continuity or quality requirements.

Global Comparison of Diclofenac Sodium Prices in Q2 2026

The regional assessments indicate a broadly declining market across North America, APAC, and Europe during the quarter ending June 2026.

Region	Average Price	Quarterly Price Index Change	Key Market Driver
USA	USD 8,170/MT	-3.199%	Distributor destocking and competitive Asian offers
China	USD 7,980/MT	-3.86%	Subdued spot buying and export competition
Germany	USD 8,050/MT	-2.64%	Cautious procurement and sufficient API availability

Note: Prices and index changes are based on the supplied Q2 2026 market assessments. The regional prices reflect different market and delivery assessments and should not be considered directly interchangeable without accounting for delivery terms, freight, and other transaction-specific costs.

China recorded the largest quarterly decline among the three assessed markets, followed by the United States and Germany. The Chinese assessment was also the lowest of the three reported average prices, while the US assessment was the highest.

These differences reflect the individual assessment bases and regional supply-demand conditions. They do not, by themselves, establish the profitability of supplying one market from another, since actual trade economics depend on manufacturing costs, freight, duties, quality requirements, and commercial terms.

Key Factors Influencing Diclofenac Sodium Prices

Pharmaceutical Demand

Demand from pharmaceutical manufacturers is a major determinant of API purchasing activity. Changes in production schedules, finished-dose medicine orders, and inventory requirements can influence the volume of Diclofenac Sodium purchased in the spot and contract markets.

Distributor Inventory Management

Destocking can reduce near-term purchasing even when downstream consumption remains stable. When distributors use existing inventories instead of replenishing them, suppliers may face slower order inflows and increased pressure to offer competitive prices.

Asian Export Competition

Competitive offers from Asian suppliers influence international sourcing decisions. Export prices can affect negotiations in North America and Europe, although differences in quality requirements, freight costs, lead times, and regulatory qualification determine the practical impact on procurement.

Manufacturing and Input Costs

Production economics can influence the prices suppliers are willing to accept. Changes in raw-material costs, energy expenses, labor, utilities, and plant operating efficiency may affect supplier margins and their flexibility to adjust quotations.

Freight and Logistics

Shipping rates, transit times, port conditions, and delivery arrangements affect the cost of moving APIs between manufacturing locations and end markets. These factors are particularly relevant when comparing FOB, CFR, and delivered-price assessments.

Quality and Regulatory Requirements

Pharmaceutical buyers must consider product quality, documentation, traceability, and supplier qualification. These requirements can influence sourcing flexibility and create differences between nominally competitive quotations and commercially viable supply options.

Book A Demo for Diclofenac Sodium Prices: https://www.chemanalyst.com/ChemAnalyst/PricingForm?Product=Diclofenac%20Sodium

Diclofenac Sodium Price Forecast: Outlook for the Second Half of 2026

The outlook for Diclofenac Sodium Prices in the second half of 2026 will depend on whether procurement demand strengthens sufficiently to absorb available supply. Following the declines recorded during Q2, market participants are likely to continue monitoring inventory levels, export quotations, pharmaceutical production schedules, and logistics costs.

A gradual recovery in distributor replenishment could support price stabilization in North America. In China, stronger export demand or reduced competitive pressure could improve suppliers' pricing positions. In Europe, changes in pharmaceutical purchasing activity and the availability of qualified API suppliers will remain important factors.

However, if buyers continue to prioritize destocking and short purchasing cycles, the market may experience further price pressure. Competitive export offers could also limit the ability of suppliers to pass higher production or logistics costs on to customers.

The forecast should therefore be considered conditional rather than a firm prediction of a specific price increase or decrease. The supplied Q2 assessments establish the direction of recent price movements, but they do not provide sufficient information to calculate a reliable numerical forecast for subsequent quarters.

Market participants should monitor the following indicators:

Changes in pharmaceutical API order volumes and distributor inventories.
Export quotations and supplier availability in China and other Asian markets.
Production costs, energy expenses, and manufacturing capacity utilization.
Freight rates, transit times, and regional import economics.
Procurement contracts, supplier qualification, and changes in customer demand.

These indicators can help buyers and suppliers distinguish temporary inventory-related weakness from a more sustained change in market fundamentals.

Conclusion

The global Diclofenac Sodium Prices market recorded a broad-based decline in Q2 2026, with lower index readings across the United States, China, and Germany. The US index decreased by 3.199% to an average price of approximately USD 8,170/MT, while China's index fell by 3.86% to around USD 7,980/MT. Germany registered a 2.64% decline, with the average price at approximately USD 8,050/MT.

Distributor destocking, subdued spot buying, competitive Asian export offers, and sufficient API availability were the principal factors behind the softer market environment. Although the magnitude of the decline differed by region, cautious procurement was a common theme across all three markets.

Looking ahead, price stabilization will depend on the recovery of purchasing activity, inventory replenishment, export demand, and changes in production and logistics costs. Buyers should continue to assess qualified suppliers, compare quotations on a consistent delivery basis, and monitor market fundamentals to support effective procurement decisions in the second half of 2026.

About Us:

Welcome to ChemAnalyst, a next–generation platform for chemical and petrochemical intelligence where innovation meets practical insight. Recognized as “Product Innovator of the Year 2023” and ranked among the “Top 100 Digital Procurement Solutions Companies,” we lead the digital transformation of the global chemical sector. Our online platform helps companies handle price volatility with structured analysis, real-time pricing, and reliable news and deal updates from across the world. Tracking over 500 chemical prices in more than 40 countries becomes simple and efficient with us.

Contact Us:

Address:

420 Lexington Avenue, Suite 300 New York, NY 10170 United States

Phone: +1 332 258 6602

Email: [email protected]

Website: https://www.chemanalyst.com/

LinkedIn: https://www.linkedin.com/company/chemanalyst/

Facebook: https://www.facebook.com/ChemAnalysts/

Twitter: https://x.com/chemanalysts

YouTube: https://www.youtube.com/@chemanalyst

Instagram: https://www.instagram.com/chemanalyst_